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A B S T R A C T A 56-yr-old black woman with absence of the eighth component of complement and a disease compatible with systemic lupus erythematosus is described. Her disease is characterized by the presence of photosensitive "malar" rash, alopecia, polyarthritis, and nephrotic syndrome.
Hemolytic and immunochemical assays of the seruim complement components were normal, except for C8 which was uindetectable. Hemolytic activity couild be restored to normal by the addition of fuinctionally puire C8. In vitro tests to investigate the ftunctional integrity of the classical and alternative pathways indicated that the functions mediated by activation of C3 and C5 were intact wNhereas heatlabile bactericidal activity was totally absent. Addition of C8 restored this function to normal levels.
One of two brothers of the proband was shown to have seruim C8 levels approaching 50% of normal indicating the hereditary natutre of the defect. HLA typing stuidies showed that the normal brother had identical haplotypes to the proband while the proposed heterozygous brother only shared one haplotype with the patient, suggesting that the gene controlling the C8 defect was not closely linked to the major histocompatibility complex. If the association of a connective tissue disease and absence of a terminal component of complement is not coincidental, these restults stuggest that C8 deficiency may be associated with a subtle defect in the defense mechanisms to viral infection leading to viral persistance and perhaps to INTRODUCTION Hereditary deficiencies of most of the individuial complement components of the hemolytic sequience have been described in man (1, 2) . Of interest is the unexpected detection of stuch complement deficiencies in patients with connective tissue diseases, particularly systemic lupuis erythematostus (SLE) . ' This association has been fouind most commonly in patients with homozygouis and heterozygous C2 deficiencies (1, 3) and in txvo patients wvitlh defects of the terminal membrane attack complex (C.5-9) (4, 5). 2 Hereditary deficiency of' the eiglhth component of complement has been previously described in one patient with disseminated gonococcemia (6, 7) . We report here a second patient with C8 deficiency and associated SLE, the immunochemical and ftunctional characteristics of the patient's serum, and the probable mode of inheritance of the defect. This unusual association in a patient where most complement-mediated functions except membrane lysis were found to be intact provides some insight on the possible mechanisms which may play a role in the pathogenesis of SLE.
PATIENT HISTORY I. C. is a 56-yr-old black woman admitted to Parkland Memorial Hospital in November 1971 for evaluation of her renal disease. She had first been seen in April 1956 complaining of pleuritic chest pain, and soon afterwards she developed nephrotic syndrome with a 24-h uirinary protein of 5.9 g. At that time LE prepara-'Abbreviationis utsed in this paper: BSA, bovine seruim albumin; CH50, hemolvtic complement; NIHC, maljor histocompatibility complex; SLE, systemic 1 uptis erythematosuts. tions were negative. In December 1957 she was admitted to the hospital with a history of weight loss of 10 pounds. alopecia, polyarthritis, fever, and a photosensitive facial rash. She had frontal alopecia, a maculopapular rash on face and forehead, generalized lymphoadenopathy, and a sterile pleural effusion. Laboratory findings: hemoglobin, 9.6 g/100 ml; normal blood leukocyte count; blood urea nitrogen, 27 mg/100 ml; serum creatinine, 2.2 mgIlO0 ml. LE preparations were again negative. The patient was given 15 mg Prednisone daily with rapid control of the fever. In (10) and C2-deficient human serum (11) . For every assay at least five normal sera were used to determine the normal range. The serum complement component levels were also measured immunochemically by the single radial immunodiffusion technique (12 Complement-dependent functions. Serum heat-labile opsonic capacity using Escherichia coli 075 was assayed as previously described (13, 14) . The functional integrity of the alternative pathway of complement activation was also assayed by incubation of serum with inulin at a concentration of 10 mg/ml at 37°C for 45 min (15) . The treated serum and a control containing 0.01 M EDTA were analyzed for the presence of C3 fragments by crossed immunoelectrophoresis (16) .
Serum bactericidal capacity was assayed by a turbidimetric method with E. coli 0111B4 according to the method of Rother et al. (17) .
Serum chemotactic activity was generated by incubation of fresh or heat-inactivated sera with 0.1 mg/ml of a bovine serum albumin (BSA), rabbit anti-BSA antigen-antibody precipitate formed at immune equivalence. The sera were incubated at 37°C for 45 min, and residual complement was then inactivated by heating at 56°C for an additional 30 min (18). Chemotaxis was measured by a modified Boyden technique (18, 19) with disposable polystyrene chambers (Adaps Inc., Dedham, Mass.) and micropore filters 3-gm pore size (Millipore Corp., Bedford, Mass.).
Solubilization of immune precipitates was performed according to the method of Czop and Nussenzweig (20) with immune precipitates containing 125I-BSA labeled by the method of MacFarlane (21) . Results were expressed as percent of solubilization (100 x cpm in supernatant fluids/total cpm).
Immunologic studies. Tissue typing was performed by Dr. Peter Stastny with a standard microcytotoxicity test (22) . Double immunodiffusion was performed with 0.6% agarose gels in cacodylate buffer, pH 7.2 (23).
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H. E. Jasin RESULTS Characterization of the C8 deficiency. Repeated determinations of total hemolytic complement since 1972 had shown undetectable hemolytic activity in the patient's serim and plasma. When the individual complement components were assayed functionally and immunochemically it was apparent that all components except C8 were within the normal range. C8 hemolytic activity was less than 0.3% of the lower limit of the normal range, and no precipitin rings were formed when the serum was assayed by radial immunodiffusion (Table I ). The sera used for these measurements were obtained when the patient was clinically inactive and the normal levels of the early complement components provide confirmation for this clinical impression.
Reconstitution of the normal hemolytic activity was attempted by the addition of several functionally pure complement components. Addition of Cl, C4, C2, C3, C5, C6, and C7 and C9 fail to reconstitute hemolytic activity, while addition of 50 U of functionally pture C8 restored total hemolytic activity to the normal level of 80 U. Addition of equal volumes of C8-deficient serum from a different patient (6) also failed to restore activity.
Furtlher confirmation of the integrity of the rest of the hemolytic sequence in the patient's serum was obtained by the preparation of EAC1-7 cells. EA were incubated at 37°C for 45 Comnplement-mediated fiunctions. Several comiiplement mediated fuinctions were tested in vitro to investigate the functional integrity of the activating sequence and of the ftunctions mediated by the third and fifth components of complement. Chemotactic activity was generated by inctubatinig sera with preformiied immnune complexes. The restults obtained indicated that the cheemotactic activity generated by sertumii I.C. wvas identical to the activity of normal serumil.
Heat-labile opsonic capacity was also tested with E. coli 075 as the microorganiismii. This test investigates botlh the integrity of the alternative path\vay an(d opsonization mediated by C3b (13, 24) . The restults obtained indicated that this futnetion wvas perfiectlv normal in serim I.C. at 5% conceintration stuggestinig that activation of the alternative pathway as well as C3 were functionally normal. These restults were confirmed by the use of intulin to activate the altern-.ative pathway. Analysis of the restulting C3 produicts by crossed immtinoelectroplhoresis slhowed no differeiwe between normial sera and the C8-deficient sertum. The degree of comiiplement-dependent solubilization of immtune complexes (25) obtained with C8-deficient seruim was identical to that of normal sera.
Sertum bactericidal capacity wvas tested because it hald been previouisly shown to depend uipon the integrity of tlhe whole sequtence of' complement activation incltuding the membrane attack complex C5-C9 (26) . E. coli 0111B4 was lysed by mosit normal sera in the albsence of specific antibody. However, I.C. sertum Nas not only uinable to kill the bacteria, buit bacteria actuially grew during the hour of' incubation at 37°C. Addition to the patient's serumil of' 100 U/ml of' functionally purified C8 restored bactericidal capacity to normal. Thus, only hemolytic and bactericidal capacities were found to be deficient in the patient's serum.
Famnily stuidies. Of' the patient's four living relatives, only two brothers were available for study. As shown in Table I , one brother (R.G.) lhad normal levels of' total hemolytic complemient and individtial components including C8, whlile the other (E.G.) showed low hemolytic comiiplemiient and rouighly one-half' of the normal concentration of' C8 both by lhem)lytic titration and immltunodiff'usion. Hemiolytic C8 titrations of' serumil f'romil the proband aind the two brothers were performed. E.G., the L)roposed heterozygote, exliibited stoiclhiomiietric C8 titrations with a calculated C8 hemolytic activity of' about 50% of normiial, whereas I.C. slhowed no detectable activity. Double immIunodiffusion analysis with a monospecific C8 antiserumiii (Fig. 1) showed decreased amounts of imiiunoreactive C8 in E.G. and normal levels in the other lbrother's serum. The proband's serum not only f:ailed to show any reactivity, but no soluble interfering material was detected as judged by inspection of' the adjacent precipitin arcs.
Possible linkage of the gene controlling C8 deficiency and the major histocompatibility region was investigated. HLA typing studies (Fig. 2) showed that the brother with normal heemolytic acnd immunoclhemical levels of C8 (R.G.) h1ad identical haplotypes to the homozygouis L)roband whereas E.G., 2 Genetic studies on C8-deficient fiasmiily. The brother with normal hemiiolytic (H) and immunocleemical (I) levels of C8 (R.G.) shows identical haplotypes to the homozygous proband while the proposed heterozygous brother (E.G.) with reduced C8 levels shares only one haplotype with the proband. I complement components except for C8 were normal both by ftunctional and immunochemical methods. That the activating sequence of hemolytic complement was intact, at least up to the seventh component, was shown by the capacity of the C8-deficient serum to generate sensitized sheep erythrocytes lysable only by the simultaneous addition of functionally pure C8 and C9 (EAC1-7) . Furthermore, the functional tests requiring the integrity of the alternative pathway, C3 and C5 such as heat-labile opsonic capacity, solubilization of immune complexes (20) , C3 breakdown upon incubation with inulin (15) , and generation of chemotactic factors (28, 29) were also shown to be normal in the patient's serum. Thus, only functions such as hemolysis and bacterial lysis, which are dependent upon the generation of functionally active membrane attack complex C5-9 (26, 30) , were fouind to be absent in the patient's serum. Inherited deficiencies of the individual components of complement except for C9 have been described (1, 2) and one patient with isolated C8 deficiency and disseminated gonococcal infection has been previously reported (6) . The immunochemical and functional characteristics of the sera from both patients seem to be quiite similar, and, furthermore, combinationi of both sera failed to reconstitute hemolytic activity suggesting that the defect in both was of identical nature.
Our patient has a 20-yr history of a disease characterized by the presence of membranous glomeruloneplhritis and clinical features compatible with SLE, but she showed positive serologic tests (LE preparations) only (luring one admission early in the disease. Atypical or absent serologic features in patients with SLE and compleinent component deficiencies have been nioticed previouisly (3, 31) .
In spite of the limited nrumber of fanmily members available for stuidy, the results obtained with HLA typing were informative. The existence of a brother wvitl one-half of the normal levels of serumln C8 (6) . Another family with the same defect has been under study and in this latter case, the C8 gene was not linked to the MIHC (33) . Recent evidence has shown that C8 is composed of three polypeptide chains of different molecular weights (34) . Thus, the complex molecular structure of C8 precltudes the designation of a unique specific locus for the C8 deficiency, and C8-deficient phenotypes may result from different genetic defects localized in different regions of the genome.
The numerous reports describing association of immune complex or connective tissue diseases with hereditary complement component deficiencies (1, 2) have stimulated muelh recent interest. The occurrence of such hereditary defects in the general population is rare (3) so that in spite of the very serious problems of ascertainmnent generated by selection bias in the case of patients affected with rheumatic disease, most investigators have accepted the hypothesis that this association is not accidental (3). Rheumatic diseases have been mostly associated with deficiency of the early acting components, particularly C2 (1-3). In patients with deficiencies of the late-acting coinponents, association with connective tissue diseases has only been rarely reported (4, 5) . Many hypotheses have been proposed to explain this association (35) (36) (37) (38) (39) (40) (41) , but so far there is no direct evidence to support any of them. Recently, the complement system has been shown to be involved in viral neutralization (42) (43) (44) , and complement defects may therefore contribute to viral persistence in patients with SLE. If the association of C8 deficiency and SLE seen in our patient is not coincidental, our findings would sUpport this mechanismin as a possible pathogenic factor since it is likely that the complement-dependent functions stuch as handling of 
